IRIS
ORSI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.170
AS - Asia 919
NA - Nord America 833
SA - Sud America 157
AF - Africa 17
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 793
RU - Federazione Russa 669
SG - Singapore 302
CN - Cina 297
IT - Italia 217
BR - Brasile 129
HK - Hong Kong 107
VN - Vietnam 85
DE - Germania 52
FR - Francia 43
SE - Svezia 43
GB - Regno Unito 40
BD - Bangladesh 31
IN - India 31
CA - Canada 23
NL - Olanda 23
PL - Polonia 18
FI - Finlandia 17
AR - Argentina 15
ES - Italia 12
MX - Messico 12
JP - Giappone 10
ZA - Sudafrica 10
AT - Austria 8
AU - Australia 8
TR - Turchia 7
AE - Emirati Arabi Uniti 6
ID - Indonesia 6
EC - Ecuador 5
IE - Irlanda 5
IQ - Iraq 5
KR - Corea 5
PK - Pakistan 5
BH - Bahrain 4
AL - Albania 3
BE - Belgio 3
LT - Lituania 3
MY - Malesia 3
VE - Venezuela 3
CO - Colombia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
TW - Taiwan 2
UA - Ucraina 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MD - Moldavia 1
MV - Maldive 1
NG - Nigeria 1
QA - Qatar 1
SA - Arabia Saudita 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 3.105
Salva come PNG Salva come JPEG
Città #
Singapore 192
Moscow 149
Dallas 128
Ashburn 114
Hong Kong 104
San Jose 101
Beijing 53
Milan 44
Shanghai 44
New York 37
Boardman 36
Hefei 31
Los Angeles 31
Lauterbourg 30
Ho Chi Minh City 26
Hanoi 22
Santa Clara 20
Warsaw 18
Cesano Boscone 14
Orem 12
Rome 12
Council Bluffs 11
Amsterdam 10
Chicago 10
London 10
Naples 10
Nuremberg 10
Stockholm 10
São Paulo 10
Brooklyn 9
Chennai 9
Helsinki 9
Munich 9
Phoenix 9
Frankfurt am Main 8
Mexico City 8
Montreal 8
Tokyo 8
Boston 7
Brescia 7
Lawrence 7
Princeton 7
Rio de Janeiro 7
Seattle 7
Atlanta 6
Denver 6
Falkenstein 6
Hyderabad 6
Johannesburg 6
Manchester 6
Mumbai 6
Sydney 6
Bologna 5
Buffalo 5
Carlsbad 5
Houston 5
Lappeenranta 5
Pisa 5
Vienna 5
Brasília 4
Campinas 4
Dhaka 4
Dublin 4
Guangzhou 4
Haiphong 4
Manama 4
Perugia 4
San Francisco 4
The Dalles 4
Toronto 4
Turin 4
Baton Rouge 3
Bellpuig 3
Brussels 3
Da Nang 3
Dubai 3
Essen 3
Fortaleza 3
Fuzhou 3
Hangzhou 3
Mezzolombardo 3
Miami 3
Milton Keynes 3
New Delhi 3
Ottawa 3
Palermo 3
Poplar 3
Porto Alegre 3
Querétaro 3
Romagnano Sesia 3
Seocho-gu 3
Thái Nguyên 3
Turku 3
Washington 3
Würzburg 3
Ankara 2
Annapolis 2
Bagé 2
Baie-D'Urfé 2
Bari 2
Totale 1.631
Salva come PNG Salva come JPEG
Nome #
ANALYSIS OF THE ACTIVITY OF NOVEL RADIOSENSITIZERS AND SYSTEMIC TREATMENTS IN PANCREATIC ADENOCARCINOMA: A ROAD MAP TO IMPROVE THE OUTCOME IN LOCALLY ADVANCED DISEASE. 161
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 157
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 153
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants 122
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 121
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 118
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 107
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 101
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 99
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 98
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 94
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 94
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 90
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease 89
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 88
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? 88
The impact of nutritional status on pancreatic cancer therapy 86
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) 84
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 84
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey. 84
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 82
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 81
Lessons and open questions in borderline resectable pancreatic cancer 79
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 77
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? 74
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology 71
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 70
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 63
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 62
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 62
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 59
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma 57
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 55
Pancreatic cancer: still a cold case? 53
The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-Analysis 43
Long-term Outcomes of EUS-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptom recurrence, reintervention timelines and stent modifications over time. 33
Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life 20
Long-term Outcomes of endoscopic ultrasound-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptom recurrence, reintervention timelines and stent modifications over time 20
Pancreatic adenocarcinoma nutritional-clinical index (PANCIN): A novel prognostic tool in advanced pancreatic cancer. 11
Clinical implications and biomarkers in the PACT-21 CASSANDRA trial – Authors' reply 5
Management of Patients with Suspected Hypersensitivity to Chemotherapy Drugs: A Practical Approach in a Tertiary Care Setting 3
Totale 3.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 5 3 0 0 1
2022/202368 14 11 5 0 1 16 3 10 2 0 6 0
2023/2024157 12 9 12 31 15 18 5 15 4 10 5 21
2024/2025575 39 11 19 22 29 59 85 76 56 65 54 60
2025/20262.389 190 160 130 254 215 79 190 187 639 141 110 94
Totale 3.198